Peer-reviewedCC BYEJNMMI research
High lesion detection rates with preoperative ⁹⁹ᵐTc-PSMA-SPECT/CT prior to radioguided surgery in biochemical recurrence: a hypothesis-generating analysis of quantitative PSMA-PET/CT parameters.
- 1Department of Nuclear Medicine, University Hospital Cologne, Cologne, Germany. [email protected].
- 2Department of Nuclear Medicine, University Hospital Cologne, Cologne, Germany.
- 3Department of Urology, University Hospital Cologne, Cologne, Germany.
Related
- Pathomic Texture Composites from H&E, and Immunohistochemistry of Prostatectomy Specimens for Exploratory Modeling of Time to Biochemical Recurrence
- Preoperative Zinc Deficiency as a Novel Prognostic Predictor for Postoperative Recurrence in Hepatocellular Carcinoma
- Preoperative thymic output and T cell repertoire diversity are associated with recurrence after nephrectomy for localized renal cell carcinoma
- A Rare Case of Appendiceal Metastasis From Prostate Adenocarcinoma in an Asymptomatic Patient With Biochemical Recurrence
- Early disease control with a biochemical response to aumolertinib after postoperative recurrence of EGFR-Mutant stage IIIA lung adenocarcinoma after icotinib, with EGFR T790M detected at recurrence: a Case Report
BibTeX
@article{ufton2026high,
title = {{High lesion detection rates with preoperative ⁹⁹ᵐTc-PSMA-SPECT/CT prior to radioguided surgery in biochemical recurrence: a hypothesis-generating analysis of quantitative PSMA-PET/CT parameters.}},
author = {Dominic Ufton and Jan Heilinger and David Pfister and Axel Heidenreich and Alexander Drzezga and Matthias Schmidt},
journal = {EJNMMI research},
year = {2026},
month = oct,
doi = {10.1186/s13550-026-01539-0},
url = {https://europepmc.org/article/MED/42955564},
note = {CC BY},
}
RIS
TY - JOUR
TI - High lesion detection rates with preoperative ⁹⁹ᵐTc-PSMA-SPECT/CT prior to radioguided surgery in biochemical recurrence: a hypothesis-generating analysis of quantitative PSMA-PET/CT parameters.
AU - Dominic Ufton
AU - Jan Heilinger
AU - David Pfister
AU - Axel Heidenreich
AU - Alexander Drzezga
AU - Matthias Schmidt
PY - 2026
DA - 2026/10/28
JO - EJNMMI research
DO - 10.1186/s13550-026-01539-0
UR - https://europepmc.org/article/MED/42955564
SN - 2191-219X
ER -